When the study performed by Hyndman36 was omitted in dominant model, Bcl-2 -938 C>A polymorphism was associated with increased cancer susceptibility (OR = 1.15, 95%CI: 1.06–1.25, P = 0.001), and the heterogeneity was obviously reduced. This evidence concerns the gene BCL2 and cancer.